Penicillin Resistance of Nonvaccine Type Pneumococcus before and after PCV13 Introduction, United States.

Academic Article

Abstract

  • Introduction of 13-valent pneumococcal conjugate vaccine in the United States was not associated with a significant change in prevalence of penicillin resistance in nonvaccine type serotypes because of the variable success of highly resistant serotypes. Differences in regional serotype distribution and serotype-specific resistance contributed to geographic heterogeneity of penicillin resistance.
  • Authors

  • Andam, Cheryl
  • Worby, Colin J
  • Gierke, Ryan
  • McGee, Lesley
  • Pilishvili, Tamara
  • Hanage, William P
  • Status

    Publication Date

  • June 2017
  • Published In

    Keywords

  • 13-valent pneumococcal conjugate vaccine
  • Anti-Bacterial Agents
  • Carrier State
  • Cross-Sectional Studies
  • Humans
  • Mass Vaccination
  • Microbial Sensitivity Tests
  • PCV13
  • Penicillin Resistance
  • Penicillins
  • Pneumococcal Infections
  • Pneumococcal Vaccines
  • Prevalence
  • Serogroup
  • Serotyping
  • Streptococcus pneumoniae
  • United States
  • Vaccines, Conjugate
  • antibiotic resistance
  • antimicrobial resistance
  • bacteria
  • bacterial infection
  • geographic variation
  • nonvaccine type
  • penicillin
  • pneumococcus
  • serotype
  • temporal variation
  • vaccines
  • Digital Object Identifier (doi)

    Start Page

  • 1012
  • End Page

  • 1015
  • Volume

  • 23
  • Issue

  • 6